| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |